Rezultaty - Runza, Valeria
- Rezultaty 1 - 4 Rezultaty od 4
-
1
Targeting Tumor Cells with Anti-CD44 Antibody Triggers Macrophage-Mediated Immune Modulatory Effects in a Cancer Xenograft Model od Maisel, Daniela, Birzele, Fabian, Voss, Edgar, Nopora, Adam, Bader, Sabine, Friess, Thomas, Goller, Bernhard, Laifenfeld, Daphna, Weigand, Stefan, Runza, Valeria
Wydane 2016Text -
2
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity od Hoves, Sabine, Ooi, Chia-Huey, Wolter, Carsten, Sade, Hadassah, Bissinger, Stefan, Schmittnaegel, Martina, Ast, Oliver, Giusti, Anna M., Wartha, Katharina, Runza, Valeria, Xu, Wei, Kienast, Yvonne, Cannarile, Michael A., Levitsky, Hyam, Romagnoli, Solange, De Palma, Michele, Rüttinger, Dominik, Ries, Carola H.
Wydane 2018Text -
3
Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia od Vey, Norbert, Delaunay, Jacques, Martinelli, Giovanni, Fiedler, Walter, Raffoux, Emmanuel, Prebet, Thomas, Gomez-Roca, Carlos, Papayannidis, Cristina, Kebenko, Maxim, Paschka, Peter, Christen, Randolph, Guarin, Ernesto, Bröske, Ann-Marie, Baehner, Monika, Brewster, Michael, Walz, Antje-Christine, Michielin, Francesca, Runza, Valeria, Meresse, Valerie, Recher, Christian
Wydane 2016Text -
4
T cell cancer therapy requires CD40-CD40L activation of tumor necrosis factor and inducible nitric oxide synthase-producing dendritic cells od Marigo, Ilaria, Zilio, Serena, Desantis, Giacomo, Mlecnik, Bernhard, Agnellini, Andrielly H.R., Ugel, Stefano, Sasso, Maria Stella, Qualls, Joseph E., Kratochvill, Franz, Zanovello, Paola, Molon, Barbara, Ries, Carola H., Runza, Valeria, Hoves, Sabine, Bilocq, Amélie M., Bindea, Gabriela, Mazza, Emilia M.C., Bicciato, Silvio, Galon, Jérôme, Murray, Peter J., Bronte, Vincenzo
Wydane 2016Text